News

The opening of this new category of coronavirus testing makes antigen the third type authorized by the FDA, following polymerase chain reaction and serological tests.

Medical journal editors call for managed expectations for the numerous clinical trials that will soon release results on potential COVID-19 treatments.

The bacterial pathogen Campylobacter jejuni has developed chicken and cattle specific strains since the rise of 20th century livestock farming.

Here is a look at some of the US FDA authorizations in the month of May so far.

Investigators detailed a promising new approach to fighting malaria with an antibody that targets a specific malaria protein, triggering the pathogen to self-destruct.

We’ve compiled a list of recalls issued by the US Food and Drug Administration (FDA) and US Department of Agriculture (USDA) from this past week:

A quick video summary of today's COVID-19 headlines.

An assessment of 1300 hospitalized patients in New York shows the rheumatic drug is neither beneficial nor harmful to reducing mortality from coronavirus.

The device, which uses a sample collected from the patient’s nose with a nasal swab and saline, will allow patients to collect their own sample and return it to a Rutgers laboratory in a sealed package for testing.

Sky-high HIV drugs costs are a significant barrier to adherence and our goal of eradicating the virus.

Moderna hopes to initiate phase 2 and late stage studies of its vaccine candidate, mRNA-1273, against COVID-19.

A quick summary of our daily COVID-19 coverage.

People who live in the same household as people who tested positive for COVID-19 had a 17% chance of becoming infected themselves, a new study found.

The hourlong test programs a CRISPR molecule to detect specific signature for SARS-CoV-2 in a series of differing test samples.

Reduced T cell count in patients with coronavirus could be as important an indicator for urgent intervention as reduced respiratory function.

A new study argues artificial intelligence will be a key tool in helping to evaluate the new barrage of new scientific research.

The 15 diagnostic guidelines weigh the currently accepted definition of coronavirus, and consider the prevalence of regional cases in at-risk patients.

Managing editor Kevin Kunzmann provides a summary of our daily COVID-19 coverage.

It is known that the type of respiratory specimen, sampling environmental factors, and time from symptom onset impact the sensitivity of rapid influenza diagnostic tests.

New data from a New York City-based hospital shows patients on blood thinners had a lower mortality risk due to COVID-19.

Investigators say they consider cefiderocol a candidate for therapeutic drug monitoring.

The data were released as part of the now-cancelled European Congress of Clinical Microbiology and Infectious Diseases.

Findings of BMC Public Health analysis suggest cost-cutting measures may delay diagnosis and treatment.

Until this week, French public health officials had believed coronavirus disease 2019 (COVID-19) had arrived in the country in January. A new study suggests it happened at least a month earlier.

An interview with the Rebiotix founder on the microbiota-based therapy and the newest preliminary pivotal phase 3 findings.

Device-related pressure injuries, moisture-associated skin damage, and skin tears were all common among Chinese clinicians treating the coronavirus.

A daily summary of our COVID-19 coverage.

A quartet of candidates will be simultaneously assessed in younger and older healthy adult patient groups in the phase 1/2 trials.